Search

everythinglearnresearchcommunity

for

Search:↓

Different medications improved various PCOS symptoms and quality of life in Pakistani women, but did not significantly help with excessive hair growth.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Finasteride reduces male rat fertility by causing issues with copulatory plug formation.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Finasteride temporarily lowers male rat fertility without affecting libido.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

Most women with PCOS have insulin resistance, especially those with phenotype B.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Patients with PCOS face poor communication and support from healthcare professionals.

Hesperidin helps protect against testicular damage caused by finasteride.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

New methods for identifying and managing polycystic ovary syndrome in teenagers are improving.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Accurate diagnosis and personalized treatment are crucial for managing women's hair loss.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Lower SHBG levels may increase the risk of PCOS.